HomeCRVS • NASDAQ
add
Corvus Pharmaceuticals Inc
Previous close
$6.06
Day range
$5.82 - $6.09
Year range
$2.54 - $10.00
Market cap
434.42M USD
Avg Volume
554.77K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 10.26M | 72.87% |
Net income | -8.00M | -87.66% |
Net profit margin | — | — |
Earnings per share | -0.13 | -83.86% |
EBITDA | -10.23M | -73.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 74.41M | 57.49% |
Total assets | 89.46M | 38.57% |
Total liabilities | 9.23M | -30.76% |
Total equity | 80.23M | — |
Shares outstanding | 74.51M | — |
Price to book | 5.61 | — |
Return on assets | -34.45% | — |
Return on capital | -38.93% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -8.00M | -87.66% |
Cash from operations | -5.78M | -5.40% |
Cash from investing | -20.30M | -15.98% |
Cash from financing | 35.77M | 17.78% |
Net change in cash | 9.69M | 31.24% |
Free cash flow | -6.14M | -264.04% |
About
Founded
2014
Headquarters
Website
Employees
31
